Dr. Steven Caplan

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.

Klaus Helm is a Dermatologist in Hershey, Pennsylvania. Dr. Helm is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Basal Cell Skin Cancer, Actinic Keratosis, and Familial Atypical Multiple Mole Melanoma Syndrome.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Acne, Prurigo Nodularis, and Rosacea.